Effects of persistent modulation of intestinal microbiota on SIV/HIV vaccination in rhesus macaques.
Ontology highlight
ABSTRACT: An effective vaccine to prevent HIV transmission has not yet been achieved. Modulation of the microbiome via probiotic therapy has been suggested to result in enhanced mucosal immunity. Here, we evaluated whether probiotic therapy could improve the immunogenicity and protective efficacy of SIV/HIV vaccination. Rhesus macaques were co-immunized with an SIV/HIV DNA vaccine via particle-mediated epidermal delivery and an HIV protein vaccine administered intramuscularly with Adjuplex™ adjuvant, while receiving daily oral Visbiome® probiotics. Probiotic therapy alone led to reduced frequencies of colonic CCR5+ and CCR6+ CD4+ T cells. Probiotics with SIV/HIV vaccination led to similar reductions in colonic CCR5+ CD4+ T cell freque
SUBMITTER: Klatt NR
PROVIDER: S-EPMC7952719 | biostudies-literature | 2021 Mar
REPOSITORIES: biostudies-literature
ACCESS DATA